期刊文献+

DC—LMP2与rAd—LMP2所诱导的细胞免疫应答效果研究 被引量:2

Comparison of immunological effect induced with DC-LMP2 and rAd-LMP2
原文传递
导出
摘要 目的比较DC-LMP2与rAd—LMP2在BALB/c小鼠中的免疫效果。方法从BALB/c小鼠中分离骨髓细胞,在细胞因子作用下体外诱导培养获得小鼠树突状细胞(mDC),再以100MOI的含EB病潜伏膜蛋白2的重组腺病毒(rAd—LNP2)感染,获得DE—LNP2,免疫酶法确定LMP2在DC中表达。于0,2,4周,分别以PBS、DC-LMP2和rAd-LMP2肌肉免疫BALB/c小鼠,第5和8周检测小鼠体内LMP2特异性细胞应答水平。结果骨髓细胞体外成功诱导获得DC,LMP2在DC中表达。DC—LMP2和rAd—LMP2均可诱导LMP2特异性细胞免疫应答,随时间推移而减弱。rAd—LMP2诱导特异性细胞免疫应答水平高于DC—LMP2。结论肌肉免疫rAd—LMP2能够在BALB/c小鼠中诱导较强的LMP2特异性细胞免疫应答。 Objective To compare immunological effect induced with DC-LMP2 and rAd-LMP2 in BALB/c mice. Mehtods Bone marrow cells were separated from BALB/c mice, and induced into murine dendritic ceils (mDCs) cultured by RPMI 1640 medium supplemented with 10% fetal calf serum and recombinant murine cytokines in vitro, mDCs were infected by recombinant adenovirus including latent membrane protein l] (LMP2) gent (rAd-LMP2) of Epstein-Barr virus(EBV) at a dose of 100 multiplicity of infection (MOI) , and matured mDC-LMP2 was harvested at 48 hours later. The LMP2 expression in mDCs was detected by immunoenzyme. BALB/c mice were immunized with PBS DC-LMP2 and rAd-LMP2 by intramuscular injection at 0,2,4 weeks. LMP2 specific cytotoxic lymphocytes (CTLs) in BALB/c mice were detected at 5th week and 8th week with enzyme-linked immunosorbent spot (ELISPOT). Results mDCs from bone marrow cells were harvested. LMP2 was detected in DC-LMP2. LMP2 specific CTLs were stimulated by both DC-LMP2 and rAd-LMP2 and decreased with time elapsed. LMP2 specific CTLs stimulated by rAd-LMP2 were higher than that by DC-LMP2 in BALB/c mice. Conclusion Immunization with rAd-LMP2 by intramuscular injection was more fitful than that with DC-LMP2 in BALB/c mice.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 2013年第6期437-439,共3页 Chinese Journal of Experimental and Clinical Virology
基金 国家“973”项目:病毒潜伏感染的分子机制(2011CB504800) 国家“863”项目:病毒性鼻咽癌疫苗关键技术研究及产品开发(2012AA02A404)
关键词 树突细胞 疱疹病毒4型 免疫 肌肉 病毒包膜蛋白质类 Dendritic cells Herpesvurus 4, human Immunity, intramuscle Viral envelope proteins
  • 相关文献

参考文献8

  • 1杜海军,王湛,尉秀霞,周玲,马晶,冯霞,叶树清,曾毅.肌肉免疫DC-EBV-LMP2诱导免疫应答的研究[J].中国医药指南,2012,10(30):1-2. 被引量:2
  • 2杨松梅,王湛,周玲,杜海军,莫武宁,曾毅.携带EBV-LMP2基因的DNA疫苗、腺相关病毒疫苗和腺病毒疫苗免疫小鼠的特异性细胞免疫应答[J].中国科学(C辑),2009,39(4):342-345. 被引量:7
  • 3姚家伟,周玲,王琦,左建民,曾毅.EB病毒潜伏膜蛋白2重组腺病毒的构建及其免疫效果的研究[J].中国肿瘤,2003,12(1):45-47. 被引量:5
  • 4Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice I Morphology quantitation tissue distribution. J Exp Med, 1973, 137 : 1142-1162.
  • 5Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev lmmunol, 1991, 9:271-296.
  • 6Lambert LA, Gibson GR, Maloney M, et al. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res,2001, 61:641-646.
  • 7Lin CL, Lo WF, Lee TH, et al Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8 T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. Cancer Res, 2002,62:6952-6958.
  • 8Smithers M,O'Connell K, MacFadyen S, et al. Clinical response 'after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen. Cancer Immunol Immunother,2003, 52:41-52.

二级参考文献36

  • 1王湛,周玲,吴小兵,卢觅佳,宣尧仙,左建民,李峰,王琦,叶树清,曾毅.Ad-LMP2重组腺病毒疫苗在恒河猴体内免疫效果的研究[J].中华实验和临床病毒学杂志,2006,20(2):63-65. 被引量:6
  • 2Chan A T, Toe P M, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol, 2002, 13:1007-1023
  • 3Yu M C. Nasopharyngeal carcinoma: epidemiology and dietary factors. IARC Sci Publ, 1991, 105:39-47
  • 4Taylor G S. T cell-based therapies for EBV-associated malignancies. Expert Opin Biol Ther, 2004, 4(1): 11-21
  • 5Lennette E T, Winberg G, Yadav M, et al. Antibodies to LMP2A/2B in EBV-carrying malignancies. EurJ Cancer, 1995, 31: 1875- 1878
  • 6Lee S P, Tierney R J, Thomas W A, et al. Conserved CTL epitopes within EBV latent membrane protein 2: a potienfial target for CTL-based tumor therapy. J Immunol, 1997, 158(7): 3325-3334
  • 7Lee S P, Chan A T, Cheung S T, et al. CTL control of EBV in nasopharyngeal carcinoma: EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. J Immunol, 2000, 165:573-582
  • 8Konishi K, Maruo S, Kato H, et al. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. J Gen Virol, 2001, 82:1451-1456
  • 9Straathof K C, Leen A M, Buza E L, et al. Characterization of latent membrane protein 2 specificity in CTL Lines from patients with EBV-Positive nasopharyngeal carcinoma and lymphoma. J Immunol, 2005, 175:4137-4147
  • 10Rooney C M, Smith C A, Ng C Y, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus related lympholiferation. Lancet, 1995, 345:9-13

共引文献9

同被引文献18

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部